Abstract # 2534 Radioimmunotherapy (RIT) using Radioactive Iodine-131; Dosimetry, Treatment, Radiation Safety and Clinical Results

Presenter: Nair, Murali

< Back to topics

> Cover Page, Authors, Institutions

> Purpose/Objective

> Materials/Methods

> Results

> Conclusions

> View tables/images/videos

We have implemented the radioimmunotherapy technique for non-Hodgkin's lymphoma as an out patient therapy procedure. All patients tolerated the treatment very well and there were no anaphylactic reaction observed during treatment and no elevation of TSH or HAMA after the treatment as evidenced from the follow up. One patient had up normal uptake in thyroid during dosimetry study and therefore, the patient was treated with Y-90 ibritumomab ( Zevalin). The clinical response; partial and complete response for 11 patients was in line with the published data.

Abstracts main page